In a post hoc analysis of the phase 3 VISION trial, investigators analyzed PSA decline and clinical and patient-reported outcomes in patients with mCRPC receiving 177Lu-PSMA-617.
Suboptimal rates of dMMR testing and immunotherapy use suggest “a need for ongoing clinician and patient education, given the survival benefit of immunotherapy in recurrent endometrial cancer,” ...
The researchers found that stratification of patients with T-ALL into low- or high-risk of relapse could be achieved using 15 genomic imbalances as a threshold. Whole-genome analysis (WGA) identified ...
HealthDay News — Newly diagnosed pancreatic cancer patients receiving palliative care (PC) consultations have an increased prevalence of anxiety and depression, according to a study recently published ...
Investigators explored the role of treatment intensification with androgen receptor pathway inhibitors in patients with high-risk localized prostate cancer.
Induction chemotherapy was associated with a 40% relative reduction in the risk of death. Adding induction chemotherapy to chemoradiotherapy improves survival outcomes in patients with locally ...
Among the factors most closely associated with feelings of distress were the deceased loved one’s disease type, their age, and the bereaved family member’s relationship with the deceased. Almost an ...
Infants exposed to chemotherapy in utero had a higher risk of severe neonatal morbidity and mortality but not pediatric complex chronic conditions or neurodevelopmental disorders and disabilities.
HealthDay News — A substantial smoking-attributable burden can be avoided by accelerating the pace of smoking elimination, according to a study published in the October issue of The Lancet Public ...